Precise Bio implants world's first 3D-printed biological cornea

In a pioneering medical procedure at the Rambam Health Care Campus in Haifa, Israel, a 70-year-old woman has partially regained her sight following the implantation of the world’s first 3D-printed biological cornea.

Developed by the Israeli biotechnology company Precise Bio, the implant was bioprinted using human cells to replicate the structure and function of a natural cornea. This breakthrough in regenerative medicine aims to address the global shortage of donor tissue, which currently affects more than 13 million people worldwide. Unlike traditional synthetic or donor-based implants, this technology allows for the creation of hundreds of implants from a single donor sample.

Ari Bat, co-founder and CEO of Precise Bio, described the successful use of a laboratory-grown implant made entirely of human cells as a “historic moment” that offers hope to millions. The technology is the result of nearly a decade of research involving engineers, researchers, and physicians to ensure high cell density and improved healing outcomes.